📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation. (2021)

First Author: Alsaadi M

Attributed to: Defining the role of FOSL2 in molecular adaptation to hypoxia in colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ph14090852

PubMed Identifier: 34577552

Publication URI: http://europepmc.org/abstract/MED/34577552

Type: Journal Article/Review

Volume: 14

Parent Publication: Pharmaceuticals (Basel, Switzerland)

Issue: 9

ISSN: 1424-8247